{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:43:59Z","timestamp":1793295839705,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Previous studies have demonstrated a close association between neddylation modifications and tumor progression as well as alterations in the microenvironment. This study aimed to explore the role of neddylation in bladder cancer (BLCA) progression and its prognostic significance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Gene expression data from the TCGA database were analyzed to identify neddylation gene modules using the limma software package and weighted gene co-expression network analysis (WGCNA). Prognostic models based on neddylation-related genes were subsequently developed through LASSO and Cox regression analyses. Additionally, a protein\u2013protein interaction (PPI) network, gene set enrichment analysis (GSEA), and BLCA single-cell sequencing data were utilized to explore the functional roles of hub genes in BLCA and their impact on biological pathways. The expression of these hub genes was further validated in clinical samples via RT-qPCR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>WGCNA analysis revealed 1412 neddylation-related hub genes. LASSO and Cox regression analyses subsequently identified six key genes: CUL1, PUM2, UBE2D3, HIF3A, COPS2, and DDB1. Transcriptomic data and RT-qPCR findings indicated that PUM2 and HIF3A exhibited high expression levels in normal tissues, while DDB1 showed increased expression in tumor tissues; no significant changes were observed for CUL1, COPS2, and UBE2D3. By integrating these gene expressions with significant clinical features, a prognostic model was constructed that demonstrated excellent diagnostic efficiency (AUC: 0.793 at 1 year, 0.792 at 3 years, and 0.773 at 5 years). In addition, single cell sequencing highlighted the potential role of these genes in modulating immune responses and mediating interactions between tumor cells and immune cells. GSEA also suggested that DDB1 may play a crucial role in orchestrating key biological processes associated with BLCA, particularly in activating apoptotic signaling pathways.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The six neddylation-related genes (CUL1, PUM2, UBE2D3, HIF3A, COPS2, and DDB1) emerge as potential independent indicators of survival in patients with BLCA, and the constructed survival models exhibit significant diagnostic efficacy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00463-y","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T12:37:12Z","timestamp":1750077432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic analysis of bladder cancer with neddylation-related genes"],"prefix":"10.1186","volume":"162","author":[{"given":"Huang","family":"Xiaolong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Sizhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Daorong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Juncheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Yanjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jie Gu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Qingjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"463_CR1","doi-asserted-by":"crossref","unstructured":"Comp\u00e9rat E, Amin MB, Cathomas R, Choudhury A, De Santis M, Kamat A, Stenzl A, Thoeny HC, Witjes JA. Current best practice for bladder cancer: a narrative review of diagnostics and treatments.lancet. 2022;400(10364):1712\u201321.","DOI":"10.1016\/S0140-6736(22)01188-6"},{"issue":"19","key":"463_CR2","first-page":"1980","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder Cancer: Rev JAMA. 2020;324(19):1980\u201391.","journal-title":"Bladder Cancer: Rev JAMA"},{"issue":"2","key":"463_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","volume":"69","author":"J Dobruch","year":"2016","unstructured":"Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, Shariat SF, Zlotta AR, Boorjian SA. Gender and bladder cancer: A collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69(2):300\u201310.","journal-title":"Eur Urol"},{"issue":"6","key":"463_CR4","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, Gupta S, Smith AB, Williams SB, Lotan Y, Epidemiology. Screening, and prevention of bladder Cancer. Eur Urol Oncol. 2022;5(6):628\u201339.","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"463_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hoc.2021.02.004","volume":"35","author":"H Ahmadi","year":"2021","unstructured":"Ahmadi H, Duddalwar V, Daneshmand S. Diagnosis and staging of bladder Cancer. Hematol Oncol Clin North Am. 2021;35(3):531\u201341.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"463_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A, Martini A, Mertens LS, Meijer RP, Milowsky MI, Neuzillet Y, Panebianco V, Redlef J, Rink M, Rouanne M, Thalmann GN, S\u00e6bj\u00f8rnsen S, Veskim\u00e4e E, van der Heijden AG. European association of urology guidelines on Muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85(1):17\u201331.","journal-title":"Eur Urol"},{"issue":"5","key":"463_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","volume":"19","author":"JY Teoh","year":"2022","unstructured":"Teoh JY, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M. Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. Nat Rev Urol. 2022;19(5):280\u201394.","journal-title":"Nat Rev Urol"},{"issue":"12","key":"463_CR8","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ijc.33794","volume":"149","author":"H Lai","year":"2021","unstructured":"Lai H, Cheng X, Liu Q, Luo W, Liu M, Zhang M, Miao J, Ji Z, Lin GN, Song W, Zhang L, Bo J, Yang G, Wang J, Gao WQ. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int J Cancer. 2021;149(12):2099\u2013115.","journal-title":"Int J Cancer"},{"issue":"7","key":"463_CR9","doi-asserted-by":"publisher","first-page":"e1338","DOI":"10.1002\/ctm2.1338","volume":"13","author":"ZD Shi","year":"2023","unstructured":"Shi ZD, Sun Z, Zhu ZB, Liu X, Chen JZ, Hao L, Zhu JF, Pang K, Wu D, Dong Y, Liu YF, Chen WH, Liang Q, Zhuo SC, Han CH. Integrated single-cell and Spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial-fibroblast interactions in recurrent bladder cancer. Clin Transl Med. 2023;13(7):e1338.","journal-title":"Clin Transl Med"},{"key":"463_CR10","doi-asserted-by":"publisher","first-page":"979262","DOI":"10.3389\/fcell.2022.979262","volume":"10","author":"Y Cui","year":"2022","unstructured":"Cui Y, Chen Z, Pan B, Chen T, Ding H, Li Q, Wan L, Luo G, Sun L, Ding C, Yang J, Tong X, Zhao J. Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma. Front Cell Dev Biol. 2022;10:979262.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"463_CR11","doi-asserted-by":"publisher","first-page":"e23181","DOI":"10.1096\/fj.202300629R","volume":"37","author":"H Liu","year":"2023","unstructured":"Liu H, Shih YH, Wang WL, Chang WL, Wang YC. UBE1C is upregulated and promotes neddylation of p53 in lung cancer. FASEB J. 2023;37(10):e23181.","journal-title":"FASEB J"},{"issue":"1","key":"463_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-019-0979-1","volume":"18","author":"L Zhou","year":"2019","unstructured":"Zhou L, Jiang Y, Luo Q, Li L, Jia L. Neddylation: a novel modulator of the tumor microenvironment. Mol Cancer. 2019;18(1):77.","journal-title":"Mol Cancer"},{"issue":"4","key":"463_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/iid3.335","volume":"8","author":"Y Lu","year":"2020","unstructured":"Lu Y, Yang X. The pivotal roles of neddylation pathway in immunoregulation. Immun Inflamm Dis. 2020;8(4):782\u201392.","journal-title":"Immun Inflamm Dis"},{"key":"463_CR14","doi-asserted-by":"publisher","first-page":"890121","DOI":"10.3389\/fcell.2022.890121","volume":"10","author":"J Zhu","year":"2022","unstructured":"Zhu J, Chu F, Zhang M, Sun W, Zhou F. Association between neddylation and immune response. Front Cell Dev Biol. 2022;10:890121.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"463_CR15","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1038\/s41467-022-30559-2","volume":"13","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Lin W, Wang C, Sun F, Ju S, Chen Q, Wang Y, Chen Y, Li H, Wang L, Hu Z, Jin H, Wang X, Sun Y. Neddylation Inhibition induces glutamine uptake and metabolism by targeting CRL3(SPOP) E3 ligase in cancer cells. Nat Commun. 2022;13(1):3034.","journal-title":"Nat Commun"},{"issue":"7","key":"463_CR16","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"463_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/1386207322666181231151900","volume":"23","author":"J Lu","year":"2020","unstructured":"Lu J, Zhang Y, Wang S, Bi Y, Huang T, Luo X, Cai YD. Analysis of four types of leukemia using gene ontology term and Kyoto encyclopedia of genes and genomes pathway enrichment scores. Comb Chem High Throughput Screen. 2020;23(4):295\u2013303.","journal-title":"Comb Chem High Throughput Screen"},{"key":"463_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"463_CR19","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"463_CR20","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"7","key":"463_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/bioinformatics\/bty750","volume":"35","author":"H Wang","year":"2019","unstructured":"Wang H, Lengerich BJ, Aragam B, Xing EP. Precision Lasso: accounting for correlations and linear dependencies in high-dimensional genomic data. Bioinformatics. 2019;35(7):1181\u20137.","journal-title":"Bioinformatics"},{"key":"463_CR22","doi-asserted-by":"publisher","first-page":"1019638","DOI":"10.3389\/fimmu.2022.1019638","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q, Qiao W, Zhang H, Liu B, Li J, Zang C, Mei T, Zheng J, Zhang Y. Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma. Front Immunol. 2022;13:1019638.","journal-title":"Front Immunol"},{"issue":"8","key":"463_CR23","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364\u201370.","journal-title":"J Clin Oncol"},{"issue":"4","key":"463_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12350-014-9908-2","volume":"21","author":"B George","year":"2014","unstructured":"George B, Seals S, Aban I. Survival analysis and regression models. J Nucl Cardiol. 2014;21(4):686\u201394.","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"463_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13059-023-03031-7","volume":"24","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Jiang S, He F, Tian Y, Hu H, Gao L, Zhang L, Chen A, Hu Y, Fan L, Yang C, Zhou B, Liu D, Zhou Z, Su Y, Qin L, Wang Y, He H, Lu J, Xiao P, Hu S, Wang QF. Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML. Genome Biol. 2023;24(1):199.","journal-title":"Genome Biol"},{"key":"463_CR26","doi-asserted-by":"publisher","first-page":"1198878","DOI":"10.3389\/fimmu.2023.1198878","volume":"14","author":"H Chen","year":"2023","unstructured":"Chen H, Yang W, Li Y, Ma L, Ji Z. Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients. Front Immunol. 2023;14:1198878.","journal-title":"Front Immunol"},{"issue":"8","key":"463_CR27","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1080\/08820139.2022.2118606","volume":"51","author":"DF Ward Grados","year":"2022","unstructured":"Ward Grados DF, Ahmadi H, Griffith TS, Warlick CA. Immunotherapy for bladder cancer: latest advances and ongoing clinical trials. Immunol Invest. 2022;51(8):2226\u201351.","journal-title":"Immunol Invest"},{"issue":"4","key":"463_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reyni\u00e8s A, Allory Y, Sj\u00f6dahl G, Robertson AG, Seiler R, Hoadley KA, Groeneveld CS, Al-Ahmadie H, Choi W, Castro MAA, Fontugne J, Eriksson P, Mo Q, Kardos J, Zlotta A, Hartmann A, Dinney CP, Bellmunt J, Powles T, Malats N, Chan KS, Kim WY, McConkey DJ, Black PC, Dyrskj\u00f8t L, H\u00f6glund M, Lerner SP, Real FX, Radvanyi F. Bladder Cancer molecular taxonomy group.a consensus molecular classification of Muscle-invasive bladder Cancer. Eur Urol. 2020;77(4):420\u201333.","journal-title":"Eur Urol"},{"issue":"14","key":"463_CR29","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.7150\/thno.78876","volume":"13","author":"ZX He","year":"2023","unstructured":"He ZX, Yang WG, Zengyangzong D, Gao G, Zhang Q, Liu HM, Zhao W. Ma LY.Targeting Cullin neddylation for cancer and fibrotic diseases. Theranostics. 2023;13(14):5017\u201356.","journal-title":"Theranostics"},{"issue":"4","key":"463_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13205-022-03162-x","volume":"12","author":"I Bano","year":"2022","unstructured":"Bano I, Malhi M, Zhao M, Giurgiulescu L, Sajjad H, Kieliszek M. A review on Cullin neddylation and strategies to identify its inhibitors for cancer therapy. 3 Biotech. 2022;12(4):103.","journal-title":"3 Biotech"},{"issue":"1","key":"463_CR31","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/cas.13865","volume":"110","author":"DW Tian","year":"2019","unstructured":"Tian DW, Wu ZL, Jiang LM, Gao J, Wu CL, Hu HL. Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer. Cancer Sci. 2019;110(1):458\u201367.","journal-title":"Cancer Sci"},{"key":"463_CR32","doi-asserted-by":"publisher","first-page":"102860","DOI":"10.1016\/j.dnarep.2020.102860","volume":"94","author":"M Beecher","year":"2020","unstructured":"Beecher M, Kumar N, Jang S, Rapi\u0107-Otrin V, Van Houten B. Expanding molecular roles of UV-DDB: shining light on genome stability and cancer. DNA Repair (Amst). 2020;94:102860.","journal-title":"DNA Repair (Amst)"},{"issue":"40","key":"463_CR33","doi-asserted-by":"publisher","first-page":"42590","DOI":"10.18632\/oncotarget.6052","volume":"6","author":"Y Sang","year":"2015","unstructured":"Sang Y, Yan F, Ren X. The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications. Oncotarget. 2015;6(40):42590\u2013602.","journal-title":"Oncotarget"},{"issue":"9","key":"463_CR34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S1568-7864(03)00113-7","volume":"2","author":"B\u00d8 Wittschieben","year":"2003","unstructured":"Wittschieben B\u00d8, Wood RD. DDB complexities. DNA Repair (Amst). 2003;2(9):1065\u20139.","journal-title":"DNA Repair (Amst)"},{"issue":"4","key":"463_CR35","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3892\/ol.2015.2926","volume":"9","author":"GG Guan","year":"2015","unstructured":"Guan GG, Wang WB, Lei BX, Wang QL, Wu L, Fu ZM, Zhou FX, Zhou YF. UBE2D3 is a positive prognostic factor and is negatively correlated with hTERT expression in esophageal cancer. Oncol Lett. 2015;9(4):1567\u201374.","journal-title":"Oncol Lett"},{"issue":"1","key":"463_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3892\/or.2017.5671","volume":"38","author":"W Wang","year":"2017","unstructured":"Wang W, Deng J, Wang Q, Yao Q, Chen W, Tan Y, Ge Z, Zhou J, Zhou Y. Synergistic role of Cul1 and c-Myc: prognostic and predictive biomarkers in colorectal cancer. Oncol Rep. 2017;38(1):245\u201352.","journal-title":"Oncol Rep"},{"key":"463_CR37","doi-asserted-by":"crossref","unstructured":"Shen J, Song R, Ye Y, Wu X, Chow WH, Zhao H. HIF3A DNA methylation, obesity and weight gain, and breast cancer risk among Mexican American women. Obes Res Clin Pract. 2020 Nov-Dec;14(6):548\u201353.","DOI":"10.1016\/j.orcp.2020.10.001"},{"issue":"12","key":"463_CR38","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3390\/cancers11121998","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Lei Y, Xu J, Hua J, Zhang B, Liu J, Liang C, Meng Q, Yu X, Shi S. Role of damage DNA-Binding protein 1 in pancreatic Cancer progression and chemoresistance. Cancers (Basel). 2019;11(12):1998.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"463_CR39","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1074\/mcp.M115.051250","volume":"15","author":"L Yang","year":"2016","unstructured":"Yang L, Wang J, Li J, Zhang H, Guo S, Yan M, Zhu Z, Lan B, Ding Y, Xu M, Li W, Gu X, Qi C, Zhu H, Shao Z, Liu B, Tao SC. Identification of serum biomarkers for gastric Cancer diagnosis using a human proteome microarray. Mol Cell Proteom. 2016;15(2):614\u201323.","journal-title":"Mol Cell Proteom"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00463-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00463-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00463-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T12:37:13Z","timestamp":1750077433000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00463-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["463"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00463-y","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was granted by the Committee of People\u2019s Hospital of Hechuan District, and all procedures adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}